CID 3012290

Schembl5757837

Structural Information

Molecular Formula
C23H22N6O3
SMILES
CCN1C2=C(C=CC=N2)N(C(=O)C3=C1N=CC(=C3)CCOC4=CC5=C(C=C4)NC(=O)N5)C
InChI
InChI=1S/C23H22N6O3/c1-3-29-20-16(22(30)28(2)19-5-4-9-24-21(19)29)11-14(13-25-20)8-10-32-15-6-7-17-18(12-15)27-23(31)26-17/h4-7,9,11-13H,3,8,10H2,1-2H3,(H2,26,27,31)
InChIKey
UFXOXCOQDMLCJI-UHFFFAOYSA-N
Compound name
2-ethyl-9-methyl-13-[2-[(2-oxo-1,3-dihydrobenzimidazol-5-yl)oxy]ethyl]-2,4,9,15-tetrazatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-10-one
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

6
Patents

430.17532 Da
Monoisotopic Mass

2.2
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 431.18260 211.1
[M+Na]+ 453.16454 222.8
[M-H]- 429.16804 213.6
[M+NH4]+ 448.20914 216.5
[M+K]+ 469.13848 217.3
[M+H-H2O]+ 413.17258 198.4
[M+HCOO]- 475.17352 221.7
[M+CH3COO]- 489.18917 217.9
[M+Na-2H]- 451.14999 213.1
[M]+ 430.17477 212.0
[M]- 430.17587 212.0
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe